Back to top

Verastem Oncology Granted Fast Track Designation for VS-7375 for the Treatment of KRAS ...

Verastem Oncology Granted Fast Track Designation for VS-7375 for the Treatment of KRAS G12D-mutated Locally Advanced or Metastatic Pancreatic Cancer | VSTM Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Verastem, Inc. (VSTM)